Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LncRNAs differentially expressed in benign and malignant phyllodes tumors [array]

ABSTRACT: lncRNAs differentially expressed in benign and malignant phyllodes tumors [array]

PROVIDER: PRJNA985635 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

lncRNAs differentially expressed in benign and malignant phyllodes tumors [array]

Project description:To investigate the pathogenesis of malignant phyllodes tumors of the breast, we used lncRNA+mRNA microarray expression profiling as a platform to investigate lncRNAs that play a key role in the malignant progression of phyllodes tumors of the breast.A total of 4 cases of breast fibroadenomas, 6 cases of benign phyllodes tumors and 6 cases of malignant phyllodes tumors were included. Fibroadenomas and benign phyllodes tumors were used as controls to screen out significantly differentially expressed lncrnas in malignant phyllodes tumors.

2024-06-20 | GSE235267 | GEO

CD146 accelerates malignant progression of phyllodes tumor cells

Project description:Breast malignant phyllodes tumors (PTs) are rapid-progressing tumors, known to lack effective treatment and suitable prognostic markers as well as elaborate studies. Herein,we found that level of CD146 is progressively elevated with malignant progression of PTs and is an independent predictor for prognosis of PT patients.Mechanistically, CD146 activates the PI3K/AKT signaling pathway, thereby enhancing malignant behaviors of PT cells.This study unveils a CD146-PI3K/AKT axis in modulating the malignant progression of PTs, and open avenues to develop a novel target for precise prognosis and treatment for breast malignant PTs.

2023-12-01 | GSE227380 | GEO

Classification of fibroadenomas and phyllodes tumors

Project description:WG-DASL expression of breast fibroepithelial lesions Breast fibroepithelial lesions are biphasic tumors and include fibroadenomas and phyllodes tumors. Fibroadenomas are clinically benign while phyllodes tumors are more unpredictable in biological behavior, with potential for recurrence. Differentiating the tumors may be challeneging when they have overlapping clinical and histological features especially on the core biopsies

2016-04-29 | GSE78071 | GEO

Differentially expressed proteins in benign and malignant adrenocortical tumors

Project description:We have compared the microsomal protein fractions from benign and malignant adrenocortical tumors. Protein extracts were trypsinized, peptides separated by HiRIEF (high resolution isoelectric focusing) and analysed by LC-MS.

2014-02-11 | PXD000604 | Pride

CD146 accelerates malignant progression of phyllodes tumor cells

Project description:CD146 accelerates malignant progression of phyllodes tumor cells

| PRJNA944931 | ENA

Expression data from benign and malignant pheochromocytomas and paragangliomas

Project description:Pheochromocytomas and paragangliomas (PPGL) are rare neuroendocrine, usually benign tumors. Currently, for these neoplasms the only reliable criterion of malignancy is the presence of metastases. The aim of the present study was to identify molecular markers that can distinguish malignant from benign PPGL. An mRNA expression array was performed on 40 benign and 11 malignant PPGL. Genes showing a significantly different expression between benign and malignant PPGL with a ratio ? 4 were selected. Differentially expressed genes were confirmed by qRT-PCR and subsequently tested in an independent validation series (4 benign and 4 malignant) by qRT-PCR. Finally, immunohistochemistry was performed for the validated genes on Tissue Micro Arrays, which included 100 PPGL (87 benign and 13 malignant). Ten genes, which were significantly differentially expressed between benign and malignant tumors (False Discovery Rates <0.05), were selected from the mRNA expression array data. Differential expression of Interleukin 13 Receptor Alpha 2 and Contactin 4 was confirmed (p<0.05) and validated by qRT-PCR. However, at the protein level, only Contactin 4 appeared to be significantly overexpressed in malignant tumors (58% in malignant versus 17% in benign; p<0.05). No difference in the immunohistochemical staining for Interleukin 13 Receptor Alpha 2 was observed between benign and malignant PPGL. Contactin 4 expression appears to be associated with malignancy in pheochromocytomas and paragangliomas, and may be predictive of malignant behavior.

2015-03-20 | GSE67066 | GEO

An Integrated Epigenomic and Genomic View on Phyllodes and Phyllodes-like Breast Tumors

Project description:Phyllodes tumor of the breast (human) as well as a set of related tumors Phyllodes tumor, Fibroadenoma, Breast Cancer

2021-07-07 | GSE179458 | GEO

Malignant Phyllodes Tumor models

Project description:Creation of a novel patient-derived xenograft and cell-line model for malignant phyllodes tumor, accompanied by characterization of effects of pazopanib therapy and its underlying mechanisms.

| PRJEB48016 | ENA

Malignant Phyllodes Tumor models

| PRJEB48011 | ENA

Methylation profiles of benign and malignant bone tumorus

Project description:Methylation profiles of benign and malignant bone tumorus

| PRJNA489284 | ENA